Related Experiment Video

Updated: Aug 24, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Positron emission tomography-based molecular imaging in human cancer: exploring the link between hypoxia and

Steven M Larson

    Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
    |April 10, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
    07:07

    Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

    Published on: February 14, 2025

    Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
    07:47

    Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

    Published on: August 31, 2022

    Related Experiment Videos

    Last Updated: Aug 24, 2026

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
    06:51

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

    Published on: July 21, 2018

    Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
    07:07

    Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

    Published on: February 14, 2025

    Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
    07:47

    Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

    Published on: August 31, 2022

    Related Concept Videos

    Positron Emission Tomography01:29

    Positron Emission Tomography

    Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
    One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
    Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

    Imaging Studies II: Positron Emission Tomography and Scintigraphy

    Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
    Fundamental Principles of PET

    Articles linked to this work by shared authors, journal, and citation graph.

    Establishment of 68Ga-DOTA-Based Pretargeted Radioimmunodiagnosis.

    Molecular pharmaceutics·2026

    Pretargeted 177Lu/225Ac combination therapy of colorectal cancer.

    Theranostics·2026

    Preclinical 203/212Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer Xenografts.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Automated Imaging as an Adjunct to Serum and Clinical Biomarkers: A New Validated Prediction Tool for Metastatic Castration-Resistant Prostate Cancer.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2025

    2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.

    Thyroid : official journal of the American Thyroid Association·2025

    Comparison of targeting two antigens (GPA33 versus HER2) for 225Ac-pretargeted alpha-radioimmunotherapy of colorectal cancer.

    Theranostics·2025

    Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Beyond Major Pathologic Response in Lung Cancer: Biomarkers Predict Outcomes.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Amivantamab plus pembrolizumab in previously untreated recurrent/metastatic head and neck squamous cell cancer: Results from the phase 1b/2 OrigAMI-4 study.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Lessons from Cohort Studies of Targetable Metabolic Deficiencies in Lung Cancer.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    KRAS Q61 NSCLC: When Alleles Matter.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    ZMIZ1 promotes aerobic glycolysis and development of hepatocellular carcinoma through inducing NOTCH1-mediated transcription of PYCR1.

    Journal of translational medicine·2026

    Parametric dynamic SPECT using a 3D CZT-ring camera for rapid characterization of disseminated splenosis.

    Seminars in nuclear medicine·2026

    CRISPR-based diagnostics as a specificity layer for the early detection of pancreatic cancer.

    Cancer letters·2026

    Molecular mechanism of augmentation of oncogenic activity of MYC by TAF2 in HCC.

    The Journal of biological chemistry·2026

    Developmental blue-light exposure alters glucose and lipid metabolism through a ROS-ACD-1-associated oxidized-lipid pathway in C. elegans.

    Free radical biology & medicine·2026

    Recent Advances in Unlocking T Cell Signatures in Cancer Through Deep Learning.

    Seminars in cancer biology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us